155 related articles for article (PubMed ID: 15033320)
1. Engineering of a recombinant Fab from a neutralizing IgG directed against scorpion neurotoxin AahI, and functional evaluation versus other antibody fragments.
Aubrey N; Muzard J; Christophe Peter J; Rochat H; Goyffon M; Devaux C; Billiald P
Toxicon; 2004 Mar; 43(3):233-41. PubMed ID: 15033320
[TBL] [Abstract][Full Text] [Related]
2. Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector.
Devaux C; Moreau E; Goyffon M; Rochat H; Billiald P
Eur J Biochem; 2001 Feb; 268(3):694-702. PubMed ID: 11168408
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant antibodies: a new application in scorpion envenomation?].
Muzard J; Billiald P; Goyffon M; Aubrey N
Bull Soc Pathol Exot; 2005 Dec; 98(5):383-5. PubMed ID: 16425719
[TBL] [Abstract][Full Text] [Related]
4. Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2.
Juárez-González VR; Riaño-Umbarila L; Quintero-Hernández V; Olamendi-Portugal T; Ortiz-León M; Ortíz E; Possani LD; Becerril B
J Mol Biol; 2005 Mar; 346(5):1287-97. PubMed ID: 15713481
[TBL] [Abstract][Full Text] [Related]
5. A recombinant scFv/streptavidin-binding peptide fusion protein for the quantitative determination of the scorpion venom neurotoxin AahI.
Aubrey N; Devaux C; di Luccio E; Goyffon M; Rochat H; Billiald P
Biol Chem; 2001 Nov; 382(11):1621-8. PubMed ID: 11767952
[TBL] [Abstract][Full Text] [Related]
6. [Rapid immunotitration of individual toxins from Androctonus australis venom].
Aubrey N; Devaux C; Billiald P
Bull Soc Pathol Exot; 2002 Aug; 95(3):194-6. PubMed ID: 12404870
[TBL] [Abstract][Full Text] [Related]
7. A novel human recombinant antibody fragment capable of neutralizing Mexican scorpion toxins.
Riaño-Umbarila L; Olamendi-Portugal T; Morelos-Juárez C; Gurrola GB; Possani LD; Becerril B
Toxicon; 2013 Dec; 76():370-6. PubMed ID: 24067940
[TBL] [Abstract][Full Text] [Related]
8. A strategy for the generation of specific human antibodies by directed evolution and phage display. An example of a single-chain antibody fragment that neutralizes a major component of scorpion venom.
Riaño-Umbarila L; Juárez-González VR; Olamendi-Portugal T; Ortíz-León M; Possani LD; Becerril B
FEBS J; 2005 May; 272(10):2591-601. PubMed ID: 15885107
[TBL] [Abstract][Full Text] [Related]
9. Antibody BCF2 against scorpion toxin Cn2 from Centuroides noxius Hoffmann: primary structure and three-dimensional model as free Fv fragment and complexed with its antigen.
Selisko B; Licea AF; Becerril B; Zamudio F; Possani LD; Horjales E
Proteins; 1999 Oct; 37(1):130-43. PubMed ID: 10451557
[TBL] [Abstract][Full Text] [Related]
10. The change of the scFv into the Fab format improves the stability and in vivo toxin neutralization capacity of recombinant antibodies.
Quintero-Hernández V; Juárez-González VR; Ortíz-León M; Sánchez R; Possani LD; Becerril B
Mol Immunol; 2007 Feb; 44(6):1307-15. PubMed ID: 16814388
[TBL] [Abstract][Full Text] [Related]
11. Bacterial expression, purification and functional characterization of a recombinant chimeric Fab derived from murine mAb BCF2 that neutralizes the venom of the scorpion Centruroides noxius hoffmann.
Selisko B; Cosío G; García C; Becerril B; Possani LD; Horjales E
Toxicon; 2004 Jan; 43(1):43-51. PubMed ID: 15037028
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of three different formats of a neutralizing single chain human antibody against toxin Cn2: neutralization capacity versus thermodynamic stability.
Quintero-Hernández V; Del Pozo-Yauner L; Pedraza-Escalona M; Juárez-González VR; Alcántara-Recillas I; Possani LD; Becerril B
Immunol Lett; 2012 Apr; 143(2):152-60. PubMed ID: 22306104
[TBL] [Abstract][Full Text] [Related]
13. Design and evaluation of a diabody to improve protection against a potent scorpion neurotoxin.
Aubrey N; Devaux C; Sizaret PY; Rochat H; Goyffon M; Billiald P
Cell Mol Life Sci; 2003 Mar; 60(3):617-28. PubMed ID: 12737321
[TBL] [Abstract][Full Text] [Related]
14. Immunological characterization of a non-toxic peptide conferring protection against the toxic fraction (AahG50) of the Androctonus australis hector venom.
Srairi-Abid N; Kaabi H; Mlayah-Bellalouna S; Mejri T; Sampieri F; El Ayeb M
Toxicon; 2008 Mar; 51(3):353-62. PubMed ID: 18054371
[TBL] [Abstract][Full Text] [Related]
15. A strategy for inducing an immune response against Androctonus australis scorpion venom toxin I in mice. Production of high-affinity monoclonal antibodies and their use in a sensitive two-site immunometric assay.
Devaux C; Clot-Faybesse O; Pugnière M; Mani JC; Rochat H; Granier C
J Immunol Methods; 2002 Dec; 271(1-2):37-46. PubMed ID: 12445727
[TBL] [Abstract][Full Text] [Related]
16. Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach.
Schlapschy M; Gruber H; Gresch O; Schäfer C; Renner C; Pfreundschuh M; Skerra A
Protein Eng Des Sel; 2004 Dec; 17(12):847-60. PubMed ID: 15708864
[TBL] [Abstract][Full Text] [Related]
17. New analysis of the toxic compounds from the Androctonus mauretanicus mauretanicus scorpion venom.
Oukkache N; Rosso JP; Alami M; Ghalim N; Saïle R; Hassar M; Bougis PE; Martin-Eauclaire MF
Toxicon; 2008 Apr; 51(5):835-52. PubMed ID: 18243273
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship of an alpha-toxin Bs-Tx28 from scorpion (Buthus sindicus) venom suggests a new alpha-toxin subfamily.
Ali SA; Wang B; Alam M; Beck A; Stoeva S; Voelter W; Abbasi A; Duszenko M
Arch Biochem Biophys; 2006 Jan; 445(1):81-94. PubMed ID: 16309623
[TBL] [Abstract][Full Text] [Related]
19. A recombinant single-chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis hector.
Mousli M; Devaux C; Rochat H; Goyffon M; Billiald P
FEBS Lett; 1999 Jan; 442(2-3):183-8. PubMed ID: 9928998
[TBL] [Abstract][Full Text] [Related]
20. A single mutation in framework 2 of the heavy variable domain improves the properties of a diabody and a related single-chain antibody.
Rodríguez-Rodríguez ER; Ledezma-Candanoza LM; Contreras-Ferrat LG; Olamendi-Portugal T; Possani LD; Becerril B; Riaño-Umbarila L
J Mol Biol; 2012 Oct; 423(3):337-50. PubMed ID: 22835504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
